NCT00149916View on ClinicalTrials.gov

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

PHASE3CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

April 30, 2004

Conditions
Renal Transplant
Interventions
DRUG

Mycophenolate sodium (enteric coated)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY